NCT05008874View on ClinicalTrials.gov

Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia

Active, not recruitingOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

June 21, 2021

Primary Completion Date

December 30, 2027

Study Completion Date

June 1, 2028

Conditions
AMNAMN Gene MutationX-ALD
Interventions
OTHER

Natural History Observation

Data collection on progression of disease

Trial Locations (6)

10065

Weill Medical College of Cornell University, New York

84112

University of Utah, Salt Lake City

94304

Stanford Neuroscience Health Center, Stanford

02114

Massachusetts General Hospital, Boston

Unknown

University of Leipzig Medical Center, Leipzig

Amsterdam UMC, Amsterdam

All Listed Sponsors
lead

SwanBio Therapeutics, Inc.

INDUSTRY

NCT05008874 - Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia | Biotech Hunter | Biotech Hunter